ERP Implementations: How to Ensure a Successful Business Go-Live

By |2023-09-19T09:58:20-04:0009/19/2023|

ERP Implementations: How to Ensure a Successful Business Go-Live This series starts with ERP Implementations: Understanding Technical Versus Business Go-Live, which focuses on why it is critical to balance the requirements of both for success. Achieving successful go-lives across both the technical and business dimensions is essential to ensuring a successful Enterprise [...]

Transitioning to Computer Software Assurance from Computer Systems Validation

By |2023-03-16T10:27:15-04:0003/29/2022|

Transitioning to Computer Software Assurance from Computer Systems Validation Life science companies need to verify that GxP computer and software systems accurately support their intended business processes. The traditional approach for meeting this requirement is computer system validation (CSV). CSV emerged decades ago when computer systems were less reliable, and software was [...]

Personal Information Protection: Broader than You Think

By |2021-11-02T10:12:07-04:0011/02/2021|

National and state governments are enacting laws to protect personal identifiable information (PII) from use without data subjects’ consent. Additionally, federal regulations are now in place to safeguard protected health information (PHI). A few examples of such laws active today are the General Data Protection Regulation by the European Union, the California Consumer Privacy [...]

Event Recap: Why is Now the Time for Digital Supply Chain Transformation

By |2023-06-28T11:42:26-04:0009/14/2021|

Event Recap: Why is Now the Time for Digital Supply Chain Transformation Clinical supply professionals are responsible for ensuring that patients on clinical trials receive the right drug at the right time for their treatment protocols. The environment is dynamic and challenging, so companies embrace innovation to enable educated and responsible supply [...]

Building Supply Chains & Systems for High-Touch Operating Models

By |2022-02-08T10:23:29-05:0008/04/2021|

Converge develops commercial supply chain business processes, commercial systems architecture & last mile strategies. Our client was an emerging pharmaceutical company focused on rare diseases, in clinical trials with an ultra-orphan drug. There were two competitive therapies also in development, so they began preparations for commercial launch on a compressed timeline to [...]

Info Sheet: IT Roadmaps for Commercial Launch

By |2021-04-08T12:51:45-04:0004/08/2021|

After spending years researching, developing, and testing innovative drug candidates, emerging biopharmaceutical companies successfully progressing in clinical development begin preparing for their first commercial launch. As this organizational transformation nears, the focus of the IT organization shifts from infrastructure and help desk support to business enablement as new functions like Sales, Medical Affairs, [...]

Info Sheet: Cell & Gene Therapy Services

By |2022-04-13T15:13:00-04:0003/02/2021|

PDF Available > Cellular and regenerative medicine introduces a shift in healthcare - the promise of using the body’s own abilities to heal. Innovation in this area is driving dramatic change in the prevention, treatment and cure of diseases and disorders. The nature of cell and gene therapies (CGT) requires rethinking traditional business models [...]

Info Sheet: Enterprise IT Strategies for Life Science

By |2021-03-19T11:56:38-04:0001/01/2020|

PDF Available > Managing enterprise information technology in emerging and growing Life Science companies is challenging beyond the typical IT dilemma. This info sheet explains how Converge develops Enterprise IT strategies in life science. Emerging biopharma companies work with limited resources, scientific and regulatory uncertainties, and strict compliance requirements. New business and information needs [...]

Scaling Clinical while Preparing for Commercial Supply

By |2022-02-08T10:28:14-05:0009/17/2019|

Introducing Demand & Operations Planning Assumptions and decisions built into clinical trial design have a major impact on emerging companies’ capacity planning and supply strategy. Protocol changes affect enrollment rates, production volumes, regulatory activities, logistics and managing data. It makes planning particularly challenging for both clinical and commercial production. Our client was [...]

Go to Top